First Trust NYSE Arca Biotechnology ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FBT and other ETFs, options, and stocks.

About FBT

FBT tracks an equal-weighted index of US biotechnology stocks. The listed name for FBT is First Trust NYSE Arca Biotechnology Index Fund. 

Index-Tracked
S&P 500 TR USD
Index-TrackedS&P 500 TR USD
Category
Health
CategoryHealth
Number of holdings
33
Number of holdings33
Inception Date
Jun 19, 2006
Inception DateJun 19, 2006

What's in this fund

Sectors

As of November 4, 2025
Healthcare100.00%

FBT Key Statistics

AUM
1.20B
AUM1.20B
Price-Earnings ratio
42.13
Price-Earnings ratio42.13
30-Day yield
30-Day yield
Average volume
23.72K
Average volume23.72K
High today
$195.86
High today$195.86
Low today
$194.03
Low today$194.03
Open price
$195.86
Open price$195.86
Volume
45.86K
Volume45.86K
52 Week high
$196.74
52 Week high$196.74
52 Week low
$141.38
52 Week low$141.38
Expense ratio
0.54
Expense ratio0.54

Stock Snapshot

First Trust NYSE Arca Biotechnology ETF(FBT) stock is priced at $195.00, giving the company a market capitalization of 1.19B. It carries a P/E multiple of 42.13 and pays a dividend yield of 22.2%.

During the trading session on 2025-11-06, First Trust NYSE Arca Biotechnology ETF(FBT) shares reached a daily high of $195.86 and a low of $194.03. At a current price of $195.00, the stock is +0.5% higher than the low and still -0.4% under the high.

Trading volume for First Trust NYSE Arca Biotechnology ETF(FBT) stock has reached 45.86K, versus its average volume of 23.72K.

The stock's 52-week range extends from a low of $141.38 to a high of $196.74.

The stock's 52-week range extends from a low of $141.38 to a high of $196.74.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.